
ProPhase Labs, Inc. Common Stock (DE)
PRPH
PRPH: ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
moreShow PRPH Financials
Recent trades of PRPH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PRPH's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Nutritional product and method of using it Aug. 30, 2022
-
Patent Title: Method and composition for the topical treatment of diabetic neuropathy Mar. 29, 2011
Federal grants, loans, and purchases
Followers on PRPH's company Twitter account
Number of mentions of PRPH in WallStreetBets Daily Discussion
Recent insights relating to PRPH
Recent picks made for PRPH stock on CNBC
ETFs with the largest estimated holdings in PRPH
Flights by private jets registered to PRPH